Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica

Antimicrob Agents Chemother. 2004 Oct;48(10):4012-5. doi: 10.1128/AAC.48.10.4012-4015.2004.

Abstract

Salmonella enterica isolates (n = 182) were examined for mutations in the quinolone resistance-determining region of gyrA, gyrB, parC, and parE. The frequency, location, and type of GyrA substitution varied with the serovar. Mutations were found in parC that encoded Thr57-Ser, Thr66-Ile, and Ser80-Arg substitutions. Mutations in the gyrB quinolone resistance-determining region were located at codon Tyr420-Cys or Arg437-Leu. Novel mutations were also found in parE encoding Glu453-Gly, His461-Tyr, Ala498-Thr, Val512-Gly, and Ser518-Cys. Although it is counterintuitive, isolates with a mutation in both gyrA and parC were more susceptible to ciprofloxacin than were isolates with a mutation in gyrA alone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Ciprofloxacin / pharmacology
  • Codon / genetics
  • DNA Gyrase / genetics*
  • DNA Gyrase / physiology
  • DNA Primers
  • DNA Topoisomerase IV / genetics*
  • DNA Topoisomerase IV / physiology
  • DNA Topoisomerases, Type I
  • Drug Resistance, Bacterial / genetics*
  • Electrophoresis, Gel, Pulsed-Field
  • Microbial Sensitivity Tests
  • Quinolones / pharmacology*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Salmonella enterica / drug effects*
  • Salmonella enterica / genetics*

Substances

  • Anti-Bacterial Agents
  • Codon
  • DNA Primers
  • Quinolones
  • Ciprofloxacin
  • DNA Topoisomerase IV
  • DNA Topoisomerases, Type I
  • DNA Gyrase